Technical Analysis for IRWD - Ironwood Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 17.29 1.17% 0.20
IRWD closed up 1.17 percent on Tuesday, September 18, 2018, on 76 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical IRWD trend table...

Date Alert Name Type % Chg
Sep 18 200 DMA Support Bullish 0.00%
Sep 18 Hammer Candlestick Bullish 0.00%
Sep 18 Lower Bollinger Band Touch Weakness 0.00%
Sep 17 Below Lower BB Weakness 1.17%
Sep 17 Lower Bollinger Band Touch Weakness 1.17%
Sep 14 Spinning Top Other -5.36%
Sep 14 NR7 Range Contraction -5.36%
Sep 13 Lower Bollinger Band Walk Weakness -4.95%
Sep 13 Lower Bollinger Band Touch Weakness -4.95%
Sep 13 Oversold Stochastic Weakness -4.95%

Older signals for IRWD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company's lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) gastrointestinal disorders under the LINZESS name in the United States and Constella name in the European Union. It also has a pipeline focused on the research and development of early development candidates and discovery research programs in various therapeutic areas, including gastrointestinal diseases, central nervous system disorders, allergic conditions, and cardiovascular diseases. Ironwood Pharmaceuticals has collaboration and license agreements with Forest Laboratories, Inc. to develop and commercialize linaclotide in North America; Almirall, S.A to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other gastrointestinal conditions; Astellas Pharma Inc. to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other gastrointestinal conditions in Japan, South Korea, Taiwan, Thailand, the Philippines, and Indonesia; and AstraZeneca AB to co-develop and co-commercialize linaclotide in China, including Hong Kong and Macau. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.
Is IRWD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 21.2
52 Week Low 12.89
Average Volume 828,676
200-Day Moving Average 16.9858
50-Day Moving Average 18.9538
20-Day Moving Average 18.334
10-Day Moving Average 17.922
Average True Range 0.6348
ADX 29.91
+DI 16.5221
-DI 34.5159
Chandelier Exit (Long, 3 ATRs ) 17.7356
Chandelier Exit (Short, 3 ATRs ) 18.7244
Upper Bollinger Band 19.5832
Lower Bollinger Band 17.0848
Percent B (%b) 0.08
BandWidth 13.627141
MACD Line -0.3681
MACD Signal Line -0.2554
MACD Histogram -0.1128
Fundamentals Value
Market Cap 2.59 Billion
Num Shares 150 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -17.64
Price-to-Sales 8.05
Price-to-Book 441.52
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.04
Resistance 3 (R3) 17.97 17.64 17.92
Resistance 2 (R2) 17.64 17.45 17.68 17.87
Resistance 1 (R1) 17.47 17.33 17.56 17.54 17.83
Pivot Point 17.14 17.14 17.19 17.18 17.14
Support 1 (S1) 16.97 16.95 17.06 17.04 16.75
Support 2 (S2) 16.64 16.83 16.68 16.71
Support 3 (S3) 16.47 16.64 16.67
Support 4 (S4) 16.54